UK Study Examines the Impact of New FSRH Guidelines on Use of EC

A recent UK study examined how the use of ulipristal acetate (UPA), levonorgestrel (LNG), and the copper-intrauterine device for emergency contraception changed following the introduction of new UK Faculty of Sexual & Reproductive Healthcare (FSRH) guidelines. The new guidelines recommend that for emergency contraception, health professionals should discuss individual needs and inform women of the different methods, efficacy, adverse effects, interactions, eligibility, and additional contraception. The researchers studied (1) how the use of EC changed, (2) which methods were offered and how this changed, (3) which method was chosen by women who were offered all three UK licensed methods of EC, and (4) the appropriateness of the offer of only LNG. The authors concluded that when comparing the period before the adoption of the new guidelines with that of the period after, more women were offered all three methods, the use of LNG fell (93.0% to 76.0%), and the use of UPA increased (3.0% to 18.7%). Additionally, women were encouraged to exercise choice. However, increasing choice did not lead to a wholesale change from LNG to UPA.


Similar Posts

  • UPA and LNG EC pills in WHO’s List of Essential Medicines

    October 2025 — Last September, the World Health Organization (WHO) published the 24th Model List of Essential Medicines (EML). Levonorgestrel (LNG) emergency contraceptive pills (ECPs) have been included in the EML since 1999, and ulipristal acetate (UPA) ECPs since 2017, underscoring their continued importance in ensuring access to safe and effective reproductive health options. Essential…

  • Canada: LNG EC free of cost in British Columbia

    April 2023. As of this month, in the Canadian province of British Columbia (BC) some brands of LNG emergency contraception pills (ECPs) are available free of cost directly from pharmacies. This gratuity scheme is run by British Columbia Pharma Care (the publicly funded program thathelps residents pay for eligible prescription drugs, and certain medical supplies…

  • UK: access to EC, coronavirus, and confidentiality

    November 2020. In September 2020, BPAS undertook a mystery shopper survey to assess whether and how pharmacies in the United Kingdom deliver the mandatory consultation for emergency contraception (EC) during the COVID-19 pandemic; and to assess whether and how easily women can access EHC without compromising on social distancing practices. In the UK EC can…

  • Argentina: New data on EC use and access

    November 2024. The Study Lucía: Uses and preferences of contraceptive methods in women aged 15 to 49 years in Argentina, was recently published. This quantitative and qualitative research has consulted 2,000 women and people identifyin as LGTB from all over the nation. The study findings, published in September 2024, include valuable information about access to…

  • New EC guidelines in Portugal

    In July 2015, the Portuguese Society of Contraception released Recomendações sobre Contraceção de Emergência, a guide for emergency contraception provision. The recommendations are based on WHO guidelines as well as ECEC’s guidelines. The guide will officially be presented at the Society’s annual meeting in September 2015. The Society is already working closely with pharmacists to…